BHLIF yields 18181.82% · JNJ yields 2.13%● Live data
📍 BHLIF pulled ahead of the other in Year 1
Combined, BHLIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BHLIF + JNJ for your $10,000?
Bradda Head Lithium Limited, through its subsidiaries, engages in the exploration, development, and mining of lithium mining projects in the United States. It holds 100% interests in Basin East located in central western Arizona, which covers an area of approximately 3.78 square kilometers (km2); Basin West consists of 65 placer mining and 72 lode claims that cover an area of approximately 6.02 km2 situated in central western Arizona; and Wikieup project comprises 120 federal placer mining claims and 225 lode claims, which covers an area of approximately 27.87 km2 located in the Mohave County, Arizona. The company also owns Wilson Salt Flat, a lithium brine project located in Nye County, Nevada; the Eureka lithium brine project covering an area of 11.8km2; and the San Domingo project consists of 68 BLM placer claims, which covers an area of approximately 13.5 km2 located in the Maricopa and Yavapai counties, Arizona. The company was formerly known as Bradda Head Holdings Limited and changed its name to Bradda Head Lithium Limited in September 2021. Bradda Head Lithium Limited is headquartered in Douglas, Isle of Man.
Full BHLIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.